FDA Says Industry Has Work Left To Do To Make Antiviral Claims For Topicals
This article was originally published in The Rose Sheet
FDA has rejected a citizen petition seeking antiviral labeling for OTC products covered by the Healthcare Antiseptic Drug Products monograph
You may also be interested in...
Rep. Ed Markey, D-Mass., wants many personal-care applications of triclosan banned and is crafting chemicals safety legislation after receiving letters from FDA and EPA acknowledging that there are concerns about the ingredient
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle